Market Recap Check: CureVac N.V (CVAC)’s Positive Finish at 4.70, Up/Down 1.51

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The price of CureVac N.V (NASDAQ: CVAC) closed at $4.70 in the last session, up 1.51% from day before closing price of $4.63. In other words, the price has increased by $1.51 from its previous closing price. On the day, 0.59 million shares were traded.

Ratios:

We take a closer look at CVAC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.63. For the most recent quarter (mrq), Quick Ratio is recorded 7.65 and its Current Ratio is at 7.65. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on April 25, 2024, Downgraded its rating to Market Perform and sets its target price to $4 from $12 previously.

On June 08, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $13.

UBS Upgraded its Neutral to Buy on January 19, 2023, whereas the target price for the stock was revised from $8 to $18.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 07 ’25 when Thaminda Ramanayake bought 6,986 shares for $3.34 per share.

Myriam Mendila bought 17,839 shares of CVAC for $88,019 on Jan 07 ’25. On Jan 07 ’25, another insider, Pierre Kemula, who serves as the affiliate of the company, bought 51,523 shares for $4.93 each.

Valuation Measures:

As of this moment, CureVac’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.84 while its Price-to-Book (P/B) ratio in mrq is 1.51.

Stock Price History:

Over the past 52 weeks, CVAC has reached a high of $5.28, while it has fallen to a 52-week low of $2.37. The 50-Day Moving Average of the stock is 37.01%, while the 200-Day Moving Average is calculated to be 45.02%.

Shares Statistics:

A total of 225.16M shares are outstanding, with a floating share count of 93.99M. Insiders hold about 58.26% of the company’s shares, while institutions hold 3.57% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.